Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

NASDAQ:LABP

Overview | Financials
Company Name Landos Biopharma, Inc.
Symbol LABP
Currency USD
Price 22.93
Market Cap 71,675,511
Dividend Yield 0%
52-week-range 3.145 - 22.94
Industry Biotechnology
Sector Healthcare
CEO Mr. Gregory Oakes
Website https://landosbiopharma.com

An error occurred while fetching data.

About Landos Biopharma, Inc.

Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and

Related Stocks

Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.

ONTX

0.995 USD

Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc.

ABEO

5.55 USD

Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.

SIOX

0.415 USD

Ekso Bionics Holdings, Inc. logo

Ekso Bionics Holdings, Inc.

EKSO

1.15 USD

Aytu BioPharma, Inc. logo

Aytu BioPharma, Inc.

AYTU

2.39 USD

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

2.08 USD

Financials

Numbers are in millions USD

Numbers are in millions USD